文献速递垂体与肾上腺疾病骨质疏松与钙磷/甲状旁腺

轻度自主皮质醇分泌对骨转换标志物的影响

The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

横断面研究纳入2014至2019年前瞻性入组的213例肾上腺腺瘤患者(22例库欣综合征、92例轻度自主皮质醇分泌、99例无功能肾上腺肿瘤),评估轻度自主皮质醇分泌对骨代谢的影响。库欣综合征患者的骨形成标志物低于轻度自主皮质醇分泌组和无功能肾上腺肿瘤组,皮质醇过量程度与硬骨素呈负相关。肾上腺切除术后骨转换标志物升高。

要点

  • 库欣综合征组骨钙素和PINP低于轻度自主皮质醇分泌组和无功能肾上腺肿瘤组。
  • 皮质醇过量程度与硬骨素水平呈负相关。
  • 肾上腺切除术后骨钙素、CTX和硬骨素升高。

核心结论

  • 轻度自主皮质醇分泌患者硬骨素水平降低反映慢性皮质醇暴露相关的骨细胞功能或数量减少。
  • 肾上腺切除术后骨转换标志物升高提示骨代谢恢复。

研究设计与样本

  • 横断面研究,2014至2019年前瞻性入组,转诊中心。
  • 纳入213例肾上腺腺瘤患者:22例库欣综合征、92例轻度自主皮质醇分泌、99例无功能肾上腺肿瘤。

主要发现

  • 库欣综合征组 vs 轻度自主皮质醇分泌组 vs 无功能肾上腺肿瘤组:平均骨钙素14.8 vs 20.1 vs 21.3 ng/mL(P < 0.0001)。
  • 库欣综合征组 vs 轻度自主皮质醇分泌组 vs 无功能肾上腺肿瘤组:平均PINP 34.8 vs 48.7 vs 48.5 µg/L(P = 0.003)。
  • 库欣综合征组 vs 轻度自主皮质醇分泌组 vs 无功能肾上腺肿瘤组:平均硬骨素419 vs 538 vs 624 ng/L(P < 0.0001)。
  • 在年龄、性别、体重指数、皮质醇和骨转换标志物的多变量模型中,硬骨素是轻度自主皮质醇分泌患者低骨量的显著预测因子(硬骨素每增加100 ng/L,OR 0.63 [95%CI 0.40-0.98])。
  • 肾上腺切除术后,骨钙素、CTX和硬骨素平均分别升高6.3 ng/mL、0.12 ng/mL和171 pg/mL(P = 0.02 for all)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Several studies have reported increased risk of fragility fractures in patients with mild autonomous cortisol secretion (MACS), discordant to the degree of bone density deterioration. OBJECTIVE: To evaluate the effect of MACS on bone metabolism in patients with adrenal adenomas. DESIGN: Cross-sectional study with prospective enrollment, 2014-2019. SETTING: Referral center. PATIENTS: 213 patients with adrenal adenomas: 22 Cushing syndrome (CS), 92 MACS and 99 nonfunctioning adrenal tumors (NFAT). MAIN OUTCOME MEASURES: Osteocalcin, procollagen I intact N-terminal (PINP), C-terminal telopeptide (CTX), sclerostin. RESULTS: Patients with CS demonstrated lower markers of bone formation compared with patients with MACS and NFAT (CS vs MACS vs NFAT: mean osteocalcin 14.8 vs 20.1 vs 21.3 ng/mL [P < 0.0001]; mean PINP 34.8 vs 48.7 vs 48.5 µg/L [P = 0.003]). Severity of cortisol excess was inversely associated with sclerostin (CS vs MACS vs NFAT: mean sclerostin 419 vs 538 vs 624 ng/L, [P < 0.0001]). In a multivariable model of age, sex, body mass index, cortisol, and bone turnover markers, sclerostin was a significant predictor of low bone mass in patients with MACS (OR 0.63 [CI 95%, 0.40-0.98] for each 100 ng/L of sclerostin increase).After adrenalectomy, osteocalcin, CTX, and sclerostin increased by a mean difference of 6.3 ng/mL, 0.12 ng/mL, and 171 pg/mL (P = 0.02 for all), respectively. CONCLUSIONS: Lower sclerostin level in patients with MACS reflects a reduction in osteocyte function or number associated with exposure to chronic cortisol excess. Increase in bone turnover markers after adrenalectomy suggests restoration of favorable bone metabolism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Athimulam S, Delivanis D, Thomas M, et al. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers. J Clin Endocrinol Metab. 2020. PMID: 32154561. doi:10.1210/clinem/dgaa120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。